Anti-IMP3 antibody [EPR12022]
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Knockout Tested Rabbit Recombinant Monoclonal IMP3 antibody. Suitable for IP, WB, ICC/IF and reacts with Human samples. Cited in 5 publications.
View Alternative Names
IMP3, KOC1, VICKZ3, IGF2BP3, Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IMP-3, IGF-II mRNA-binding protein 3, KH domain-containing protein overexpressed in cancer, VICKZ family member 3, hKOC
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IMP3 antibody [EPR12022] (AB177942)
Immunofluorescent analysis of HeLa cells labeling IMP3 with ab177942 at 1/50 dilution (green). DAPI nuclear staining (blue).
- IP
Supplier Data
Immunoprecipitation - Anti-IMP3 antibody [EPR12022] (AB177942)
Western blot analysis on immunoprecipitation pellet from 293T cell lysate using ab177942.
All lanes:
Immunoprecipitation - Anti-IMP3 antibody [EPR12022] (ab177942)
Predicted band size: 63 kDa
false
- WB
Lab
Western blot - Anti-IMP3 antibody [EPR12022] (AB177942)
Western blot : Anti-IGF2BP3 antibody [EPR12022] (ab177942) staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab177942 was shown to bind specifically to IGF2BP3. A band was observed at 60-75 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in IGF2BP3 knockout cell line. To generate this image, wild-type and IGF2BP3 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-IMP3 antibody [EPR12022] (ab177942) at 1/2000 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
IGF2BP3 knockout HCT 116 cell lysate at 20 µg
Lane 3:
Wild-type HAP1 cell lysate at 20 µg
Lane 4:
IGF2BP3 knockout HAP1 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
false
- WB
Lab
Western blot - Anti-IMP3 antibody [EPR12022] (AB177942)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : IGF2BP3 (IMP3) knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HEK293 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab177942 observed at 70 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab177942 was shown to specifically react with IGF2BP3 (IMP3) in wild-type HAP1 cells as signal was lost in IGF2BP3 (IMP3) knockout cells. Wild-type and IGF2BP3 (IMP3) knockout samples were subjected to SDS-PAGE. ab177942 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IMP3 antibody [EPR12022] (ab177942)
Predicted band size: 63 kDa
false
- WB
Supplier Data
Western blot - Anti-IMP3 antibody [EPR12022] (AB177942)
All lanes:
Western blot - Anti-IMP3 antibody [EPR12022] (ab177942) at 1/1000 dilution
Lane 1:
Hela cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Lane 4:
HT-29 cell lysate at 10 µg
Predicted band size: 63 kDa
Observed band size: 69 kDa
false
Related conjugates and formulations (1)
-
Anti-IMP3 antibody [EPR12022] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IMP3 plays a role in the regulation of mRNA stability localization and translation. It is a part of ribonucleoprotein complexes that facilitate these processes by binding to the 3' untranslated regions of target mRNAs. The protein influences the expression of genes involved in cell growth differentiation and migration. IMP3's ability to modulate mRNA fate contributes to cellular events essential for development and has implications in cancer progression.
Pathways
The involvement of IMP3 is significant in pathways like the insulin-like growth factor (IGF) signaling pathway and epithelial-mesenchymal transition (EMT). Within these pathways IMP3 modulates the activities of proteins such as IGF2 influencing cell proliferation and survival. Its participation in EMT is essential for processes like metastasis in cancer cells linking it to broader biological processes that govern cell movement and identity change.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cell death and differentiation : PubMed41053177
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 23:330 PubMed38110984
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6876 PubMed37898647
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell transplantation 29:963689720964382 PubMed33028109
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 35:3495-502 PubMed26522719
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com